OnKure Therapeutics Inc. (OKUR)
NASDAQ: OKUR
· Real-Time Price · USD
2.85
0.32 (12.65%)
At close: Aug 18, 2025, 2:30 PM
OnKure Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Net Income | -60.31M | -59.06M | -52.67M | 1.04M | -42.12M | -36.17M | -35.31M | -53.83M | -16.86M | -8.68M |
Depreciation & Amortization | 787K | 723K | 662K | 474K | 576K | 583K | 560K | 126K | 283K | 128K |
Stock-Based Compensation | 8.26M | 7.17M | 4.53M | -701K | 2.09M | 291K | 199K | 3.79M | 32K | 15K |
Other Working Capital | -18.62M | -12.92M | -13.17M | -15.41M | 9.99M | 1.2M | 4.8M | 8.14M | 901K | 3.98M |
Other Non-Cash Items | 10.03M | 11.04M | 11.04M | 11.13M | 9.52M | 9.52M | 9.52M | 7.36M | n/a | -1K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -9.34M | -3.64M | -3.95M | -21.94M | 3.46M | -5.33M | 6K | 8.14M | 901K | 3.98M |
Operating Cash Flow | -50.58M | -43.77M | -40.4M | -10M | -26.49M | -31.11M | -25.03M | -34.41M | -15.65M | -4.55M |
Capital Expenditures | -64K | -61K | -52K | -52K | -194K | -244K | -246K | -196K | -71K | -11K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 67.75M | 67.75M | 67.75M | 190.06M | 190.06M | 190.06M | 190.06M | n/a | n/a | n/a |
Sales Maturities Of Investments | -88.08M | -88.08M | -88.08M | -136M | -161M | -161M | -161M | n/a | n/a | n/a |
Other Investing Acitivies | -17K | -17K | -17K | -17K | 21.38M | 21.38M | 21.38M | 21.38M | n/a | n/a |
Investing Cash Flow | -20.41M | -20.4M | -20.39M | 53.99M | 50.24M | 50.19M | 50.19M | 21.18M | -71K | -11K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 57.29M | 63.15M | 63.19M | 60.94M | -5.86M | -11.72M | -12.44M | -65.5M | -724K | -716K |
Financial Cash Flow | 116.14M | 122.01M | 122.1M | -3.99M | -5.82M | -11.69M | 41.41M | 53.28M | 53.11M | 53.11M |
Net Cash Flow | 47.4M | 60.08M | 63.55M | 31.61M | 9.55M | -988K | 58.18M | 40.05M | 37.39M | 48.54M |
Free Cash Flow | -61.36M | -54.55M | -51.17M | -20.77M | -36.2M | -40.87M | -34.79M | -44.13M | -15.72M | -4.56M |